http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021083382-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8205ec6ee1cd95eb60a03826535bad97 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate | 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a373133553a8e560ac71ed95abedb107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8522f94f7e9325632b4d65852a01e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0936769bf010963ffd385277631a4893 |
| publicationDate | 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021083382-A |
| titleOfInvention | Kinase inhibitor |
| abstract | PROBLEM TO BE SOLVED: To provide a novel kinase inhibitor. Kinase inhibitors containing compounds represented by the following general formula (I) or salts thereof: {In the formula, R 1 is hydrogen, an alkyl group or aryl group having 1 to 6 carbon atoms which may have a substituent, and R 2 is hydrogen or an alkyl group or aryl group which may have a substituent and has 1 to 6 carbon atoms. Alkyl groups of, or R 1 and R 2 together form − (CH 2 ) n − (in the formula, n is 2, 3, 4, or 5), where R 3 is hydrogen, −CONH. -CH 3 or -NHCO-CH 3 . } [Selection diagram] None |
| priorityDate | 2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.